MedTrace Logo

Skin Care Regimen for Improving Photoaging Signs on the Face

NCT06603857 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-09-19

No results posted yet for this study

Summary

Compare the effectiveness of laser treatment using CE Ferulic versus vehicle pre/post laser.

Conditions

  • Improve Photoaging Signs

Interventions

DRUG

CE Ferulic

CE Ferulic serum regimen combined with laser treatment

DRUG

Sham Comparator

Vehicle serum regimen combined with laser treatment

DEVICE

1927nm (Clear and Brilliant Perméa®)

non-ablative fractional diode laser

Sponsors & Collaborators

  • L'Oreal

    collaborator INDUSTRY

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-27
Primary Completion
2024-12-31
Completion
2025-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06603857 on ClinicalTrials.gov